Complication of 'Fat Freezing' Procedure May Be More Common Than Thought
Cryolipolysis is a noninvasive cosmetic procedure that eliminates excess fat by freezing it. But a complication called paradoxical adipose hyperplasia (PAH) –a hardened area of localized fat developing after cryolipolysis – may be more common than previously thought, suggests a paper in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
While PAH can be treated successfully with liposuction, patients must wait a few months before treatment, according to the study, led by ASPS Member Surgeons Michael E. Kelly, MD, and Jose Rodríguez-Feliz, MD, of Miami Plastic Surgery. "Surgeons must be extremely sensitive when dealing with patients who have PAH, both when explaining the problem and when offering them a potential surgical solution," the researchers write.
PAH after Cryolipolysis May Not Be a 'Rare' Complication
Drs. Kelly and Rodríguez-Feliz and colleagues share their experience in managing patients with PAH after cryolipolysis: an FDA-approved procedure that works by destroying cold-sensitive subcutaneous fat cells. It has become a popular technique for treating problem fat areas such as belly fat and "love handles."
Paradoxical adipose hyperplasia has been reported as a rare adverse event after cryolipolysis. In this condition, the treated area becomes larger rather than smaller in the weeks after the procedure, leaving a "painless, visibly enlarged, firm, well-demarcated mass" under the skin. Based on data from the manufacturer of the cryolipolysis equipment, PAH has been estimated to occur in 1 out of every 4,000 treatment cycles, for an incidence of 0.025 percent.
The authors describe their experience with 11 patients with PAH. Six patients underwent cryolipolysis at the authors' clinic and five were referred from other practices. The authors note that their experience of 15 PAH events in six patients represents a much higher incidence: 0.72 percent, or about 1 out of every 138 cryolipolysis treatments.
The good news is that PAH was successfully treated in all cases. Most patients needed liposuction only; one patient had liposuction combined with an abdominoplasty ("tummy tuck") procedure. Dr. Rodríguez-Feliz recommend the use of a power-assisted liposuction technique. All patients achieved good cosmetic results and were very satisfied with their final appearance. However, the patients had to wait several months for treatment. That time is needed for the fat in the area of PAH to soften; otherwise, there is a risk that PAH could recur. In some cases, more than one liposuction treatment was needed.
Drs. Kelly and Rodríguez-Feliz and colleagues acknowledge that it's "very upsetting" for patients who initially sought a noninvasive fat reduction procedure to be faced with the need for an invasive procedure (liposuction) to correct the problem. Two patients with PAH refused further treatment, even though the treatment costs were covered by the manufacturer of the cryolipolysis equipment.
Patients are "initially aggravated by the delay and require continuing reassurance that the problem will ultimately be resolved," the authors note. "Counseling is extremely important during this waiting period." The online version of the article on the Plastic and Reconstructive Surgery website includes a video illustrating the clinical examination findings in a patient with PAH.
"Despite these hurdles, patient satisfaction with the final surgical cosmetic result has been high," Drs. Kelly and Rodríguez-Feliz and coauthors conclude. They emphasize the need for further study to clarify the incidence of PAH after cryolipolysis, to identify possible risk factors, and to evaluate the long-term outcomes of liposuction to correct the problem.
Click here to read "Treatment of Paradoxical Adipose Hyperplasia following Cryolipolysis: A Single-Center Experience"
Article: "Treatment of Paradoxical Adipose Hyperplasia following Cryolipolysis: A Single-Center Experience" (doi: 10.1097/PRS.0000000000004523)
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.